Search research articles
Contact Us
Filters
Showing results (11-20 of 151) with videos related to
Page
of 16
Sort By:
Heart Rhythm
|
May 27, 2009
Risk stratification for sudden death in patients with coronary artery disease
Alfred E Buxton
Heart Rhythm
|
June 25, 2011
Sudden cardiac death won't go away: what are we to do?
Alfred E Buxton
Annals of Internal Medicine
|
March 18, 2003
The clinical use of implantable cardioverter defibrillators: where are we now? Where should we go?
Alfred E Buxton
Medicine and Health, Rhode Island
|
June 1, 2004
Direct current cardioversion for atrial fibrillation and flutter
Alfred E Buxton
JACC. Clinical Electrophysiology
|
September 5, 2025
Conduction Block Complicating Transcutaneous Aortic Valve Replacement: Many Unanswered Questions
Alfred E Buxton, Peter Zimetbaum
International Journal of Cardiology
|
August 23, 2018
Identification of suitable patients for ICD therapy
Heikki Huikuri, Alfred E Buxton
Cardiac Electrophysiology Clinics
|
November 28, 2017
Primary Prevention Implantable Cardiac Defibrillator Trials: What Have We Learned?
Jakub Sroubek, Alfred E Buxton
JAMA
|
May 29, 2013
Personalized medicine vs guideline-based medicine
Jeffrey J Goldberger, Alfred E Buxton
Annual Review of Medicine
|
February 8, 2018
Risk Stratification for Sudden Cardiac Death After Myocardial Infarction
Jonathan W Waks, Alfred E Buxton
JAMA Cardiology
|
October 4, 2017
Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When is the Most Clinically Relevant Time to Evaluate?-Reply
Selcuk Adabag, Kristen K Patton, Alfred E Buxton
Page
of 16
Search research articles
Search
Showing results (11-20 of 151) with videos related to
Sort By:
Page
of 16
Heart Rhythm
|
May 27, 2009
Risk stratification for sudden death in patients with coronary artery disease
Alfred E Buxton
Heart Rhythm
|
June 25, 2011
Sudden cardiac death won't go away: what are we to do?
Alfred E Buxton
Annals of Internal Medicine
|
March 18, 2003
The clinical use of implantable cardioverter defibrillators: where are we now? Where should we go?
Alfred E Buxton
Medicine and Health, Rhode Island
|
June 1, 2004
Direct current cardioversion for atrial fibrillation and flutter
Alfred E Buxton
JACC. Clinical Electrophysiology
|
September 5, 2025
Conduction Block Complicating Transcutaneous Aortic Valve Replacement: Many Unanswered Questions
Alfred E Buxton, Peter Zimetbaum
International Journal of Cardiology
|
August 23, 2018
Identification of suitable patients for ICD therapy
Heikki Huikuri, Alfred E Buxton
Cardiac Electrophysiology Clinics
|
November 28, 2017
Primary Prevention Implantable Cardiac Defibrillator Trials: What Have We Learned?
Jakub Sroubek, Alfred E Buxton
JAMA
|
May 29, 2013
Personalized medicine vs guideline-based medicine
Jeffrey J Goldberger, Alfred E Buxton
Annual Review of Medicine
|
February 8, 2018
Risk Stratification for Sudden Cardiac Death After Myocardial Infarction
Jonathan W Waks, Alfred E Buxton
JAMA Cardiology
|
October 4, 2017
Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When is the Most Clinically Relevant Time to Evaluate?-Reply
Selcuk Adabag, Kristen K Patton, Alfred E Buxton
Page
of 16